InvestorsHub Logo
Followers 87
Posts 6734
Boards Moderated 1
Alias Born 09/18/2009

Re: Preciouslife1 post# 42020

Thursday, 03/07/2024 11:06:39 AM

Thursday, March 07, 2024 11:06:39 AM

Post# of 43060
Interesting niche. But I don't see anything about production turnaround, and it appears that their CAR-T is designed to enhance mitigation of CCR-9. I think Gracell's 24 hour turnaround for CAR-T is a much better, even revolutionary, alternative, which I hope that lenz is a part of making that happen.

I see that they also provide CRISPR services. I think that lenz was developed with that gene-editing technology. But even so, I'm not comfortable with it, generally. And I see that GenScript also provides mRNA solutions, and I am becoming increasingly wary of that.

Lots and lots of potential with those technologies, but way too much opportunity for abuse of those capabilities.

https://www.genscript.com/?src=google&utm_source=google&utm_medium=cpc&utm_campaign=GenScript-ECPC_NA&jiraid=12194&gad_source=1&gclid=EAIaIQobChMIzsnPnL_ihAMVGy7UAR2UUQsxEAAYASAAEgJy3vD_BwE
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.